# Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)

> **NCT02569164** · — · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Urinary Albumin Excretion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02569164
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569164, "Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02569164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*